国际标准期刊号: 2684-1630
Mohammad Unisha
SLE is a multisystemic autoimmune disease that causes severe morbidity and mortality. A bidirectional pattern of life threatening has been well-conceived , with early fatalities most typically due to active SLE or infection and late deaths primarily due to atherosclerotic vascular disease. Indeed in multiple SLE cohorts, short disease duration has been found to be a separate risk factor for infections.Infections are commonly thought to be a consequence of immunosuppressive therapy in SLE patients, nevertheless as many as 25.9% of serious infections are documented at the point of SLE identification regardless of immunosuppressive treatment.